Business Context and Reporting Period
Company: Astro-Med, Inc. (Note: Input metadata referenced "Astronova, Inc.", but the filing text identifies the registrant as Astro-Med, Inc.)
Filing Type: Form 10-Q (Quarterly Report)
Reporting Period: Quarter and nine months ended November 3, 2001.
Business Overview: The company operates in three primary product groups: QuickLabel Systems (QLS), Test & Measurement (T&M), and Grass-Telefactor (neurophysiology monitoring systems).
Key Financial Metrics
| Metric | Three Months Ended Nov 3, 2001 | Nine Months Ended Nov 3, 2001 |
|---|---|---|
| Net Sales | $12,398,711 | $36,966,427 |
| Gross Profit | $4,441,243 | $14,259,310 |
| Gross Margin | 35.8% | 38.6% |
| Operating Loss | $(424,990) | $(727,642) |
| Net Loss | $(229,739) | $(274,132) |
| Loss Per Share (Basic/Diluted) | $(0.05) | $(0.06) |
| Cash Flow from Operations | N/A | $143,258 |
| Cash and Equivalents (End of Period) | $1,631,830 | $1,631,830 |
| Total Debt (Current + Long-Term) | $36,912 | $36,912 |
Note: Long-term debt was fully paid off or reclassified; only current maturities of $36,912 remain as of Nov 3, 2001.
Material Changes vs. Prior Period
- Revenue: Quarterly sales increased 4% to $12.4M, driven by a 24% surge in international sales. Nine-month sales declined 2% to $37.0M due to a 3% drop in domestic sales.
- Profitability: Net loss improved significantly in the quarter, dropping from $698,000 in the prior year to $230,000. Nine-month net loss remained relatively flat at $274,000 compared to $272,000 in the prior year.
- Cash Flow: Operating cash flow turned positive, providing $143,000 for the nine-month period, compared to a usage of $1.6M in the prior year.
- Product Mix: QLS sales were a record high (up 21% quarterly), while T&M sales declined 4% quarterly due to a 31% drop in international T&M sales. Grass-Telefactor sales fell 8% quarterly.
- Expenses: SG&A expenses decreased 7% in the quarter due to prior workforce reductions. R&D spending increased slightly in the quarter but decreased 12% year-to-date.
Outlook, Risks, and Management Commentary
- Liquidity: The company holds $5.16M in cash and securities. It maintains a $2.0M line of credit (fully available) and has $3.5M in total unused borrowing capacity.
- Operational Efficiency: The collection cycle improved to 58 days from 66 days. Inventory levels remained stable with a turnover of 2.5 times.
- Risks: Management cites economic uncertainty causing customers to delay acquisitions of monitoring systems. Specific risks include declining demand in defense/aerospace (T&M), competition in specialty printers, and foreign currency exchange rate fluctuations.
- Unusual Items: "Other, Net" income improved due to a $125,000 gain from litigation settlement and a $25,000 gain on asset sales. Foreign exchange results improved from a loss in the prior year to a gain in the current period.
- Dividends: The company declared dividends of $0.04 per share for the quarter and $0.12 for the nine-month period.
Investor Verification Checklist
- Revenue Sustainability: Verify if the 24% international sales growth is sustainable given the noted economic uncertainty and 31% drop in international T&M sales.
- One-Time Gains: Assess the impact of the $125,000 litigation settlement and $25,000 asset sale gain on the "Other, Net" income line.
- Product Pipeline: Confirm the market acceptance timeline for new T&M products (Everest and Dash 18) mentioned as drivers for domestic growth.
- Debt Covenants: Review the terms of the new $2.0M line of credit to ensure no restrictive covenants are triggered by the operating losses.
- Inventory Valuation: Monitor inventory levels ($10.8M) relative to the 2.5x turnover rate to ensure no obsolescence risks, particularly for delayed monitoring system orders.